22/01/2026
ππππππ πππππππ πππππππ ππππππππππππ π
ππ-πππππππ ππππππππππππ πππ ππππππππ
The Food and Drug Administration (FDA) warns the public and regulated establishments against individuals who falsely represent themselves as FDA officers, employees, or accredited consultants and who solicit money in exchange for the facilitation, expediting, or guarantee of FDA approvals or regulatory actions.
The FDA does not authorize any individual or private entity to collect payments or offer services on its behalf. All FDA applications and transactions are processed only through official FDA offices and platforms, in strict accordance with existing laws, rules, regulations, and the FDA Citizenβs Charter. Any transaction outside these official channels is UNAUTHORIZED and ILLEGAL.
The FDA emphasizes that regulatory decisions are and will be based solely on completeness and compliance with safety, quality, and efficacy standards.
The public is strongly encouraged to report fixers, unauthorized consultants, or any individual who solicits payments in connection with FDA transactions. Reports may be made through the Food and Drug Action Center (FDAC) via its official hotlines at (02) 8257-1957, (02) 8286-6087, (02) 8273-048, (02) 8800-4392, (02) 8273-3756, and (02) 8659-7330, or through email at [email protected] or [email protected].
The FDA remains committed to integrity, transparency, and accountability in protecting public health.